7
Views
4
CrossRef citations to date
0
Altmetric
Original Contributions

Appearance Of A Novel Prostacyclin Receptor Antibody and Duration Of Spinal Cord Injury

, PhD, , MD & , DSc
Pages 97-102 | Received 19 Oct 2004, Accepted 10 Feb 2005, Published online: 01 Sep 2016

References

  • Bauman WA, Kahn NN, Grimm DR, Spungen AM. Risk factors for atherogenesis and cardiovascular autonomic function in persons with spinal cord injury. Spinal Cord. 1999;37:601–616.
  • Phillips WT, Kiratli BL Sarkarati M, et al. Effect of spinal cord injury on the heart and cardiovascular fitness. Curr Probl Cardia/. 1998;23:641–716.
  • Bauman WA, Raza MA, Spungen AM, et al. Tomographic thallium myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia. Arch Phys Med Rehabil. 1993;174:740–744.
  • Kahn NN, Sinha AK, Bauman WA. Impaired platelet prostacyclin receptor activity: a monozygotic twin study discordant for spinal cord injury. Clin Physiol. 2001 ;21 :60–66.
  • Rossi EC, Green D, Rosen JS, et al. Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury. Br j Haematol. 1980;45: 143–151.
  • Perkash A, Perkash V, Perkash I. Experiences with management of thromboembolism in patients with spinal cord injury: part 1 . Incidence, diagnosis and role of risk factors. Paraplegia. 1979;16:322–331 .
  • Lamb GC, Tomski MA, Kaufman L et al. Is chronic spinal cord injury associated with increased risk of venous thromboembolism? jAm Paraplegia Soc. 1993;16:153–156
  • Kahn NN. Platelet-stimulated thrombin generation and PDGF are normalized by insulin and Ca2+channel blockers. Am j Physiol. 1999;276(39):E856–862.
  • Cimminiello CG, Arpaia M, Aloisio M, et al. Platelet-derived growth factor (PDGF) in patients with different degrees of chronic arterial obstructive disease. Angiology. 1994;45: 289–293.
  • Badimon L, Cheseboro JH, Badimon jj. Thrombus formation on ruptured atherosclerotic plaques and rethrombosison evolving thrombi. Circulation. 1992;86(Suppl 6)111:74- 85 .
  • Colman RW, Marder VL Salzman EW, et al. Overview of hemostasis and thrombosis. In : Colman RW, Hirch L Marder VL Salzman EW, eds.Hemostasis and Thrombosis. Philadelphia, PA: Lippincott; 1987;3–17.
  • Kahn NN, Sinha AK. Stimulation of prostaglandin E1 binding to human platelet membrane by insulin and the activation of adenylate cyclase. j Bioi Chem. 1990;265: 4976–4981.
  • Kahn NN, Muellar HS, Sinha AK. Restoration by insulin of impaired prostaglandin E1/ 12 receptor activity of platelets in acute ischemic heart disease. Circ Res. 1991 ;68:245–254.
  • Gieger L Noltec C, Walter U. Regulation of calcium mobilization and entry in human platelets by endothelialderived factors. Am j Physiol. 1994;267(Ce// Physiol. 36):C236–244.
  • Kahn NN, Bauman WA Sinha AK. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans. Am j Physiol. 1993;34:H2160.
  • Kahn NN, Bauman WA, Sinha AK. Loss of high-affinity prostacyclin receptors in platelets and the lack of prostaglandin- induced inhibition of platelet-stimulated thrombin generation in subjects with spinal cord injury. Proc Nat/ Acad Sci US A. 1996;93:245–249.
  • Siegl AM, Smith jB, Silver ML Nicolaou KC, Ahern D. Selective binding sites for 3H-prostacyclin on platelets. j Clin Invest. 1979;63:215–220.
  • Kahn NN, Bauman WA, Sinha AK. Demonstration of a novel circulating anti-prostacyclin receptor antibody. Proc Nat/ Acad Sci U SA. 1997;94:8779–8782.
  • Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acd Sci. 1949;51 :666–672.
  • Dutta-Roy AK, Sinha AK. Purification and properties of prostaglandin E1 / 12 receptor of human blood platelets. j Bioi Chem. 1987;262(26):12685–12691.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 1970;227:680–685.
  • Demirel S, Demirel G, Tukek T, et al. Risk factors for coronary heart disease in patients with spinal cord injury in Turkey. Spinal Cord. 2001;39(3):134–138.
  • Mueller CA, Schuesener HL Conrad S, et al. Spinal cord injury induces lesional expression of the proinflammatory and antiangiogenic cytokine EMAP II. j Neurotrauma. 2003; 20(1 0):1 007–1015.
  • Hayes KC, Hull TC, Delaney GA, et al. Elevated serum titers of proinflammatory cytokines and CNS autoantibodies in patients with spinal cord injury. j Neurotrauma. 2002; 19(6):753–761.
  • Resetkova E, Morita T, Akasu F, Carayon P, Volpe R. In vitro effects of cytokines and human thyroglobulin on the induction of antibody-secreting cells in patients with auto-immune thyroid disease. Clin Invest Med. 1993; 16(4):256–264.
  • Dong G, Ye R, Shi W, et al. IL-17 induces autoantibody overproduction and peripheral blood mononuclear cell overexpression of IL-6 in lupus nephritis patients. Chin Med j (Eng/). 2003;116(4):543–551 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.